Cent

Quick links to important sections

Cent

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cent

Property Description
Active ingredient Cetirizine Dihydrochloride
Form Oral tablet, solution, syrup, or capsule
Pharmacological class H₁-Receptor Antagonist (Second-Generation Antihistamine)
General purpose Relief from allergic physical manifestations
Origin Synthetic metabolite of Hydroxyzine

Cent is a medicinal preparation whose active ingredient is Cetirizine Dihydrochloride, classified as a modern, second-generation antihistamine. It is a synthetic compound derived as a carboxylic acid metabolite of the older piperazine-class drug, Hydroxyzine, which dictates its distinct chemical and physiological profile.


What Type of Medicine is Cent and How Does it Differ?

Cent belongs to the second-generation class of H₁-receptor antagonists, a highly selective pharmacological class used in anti-allergic therapy. The classification of Cetirizine Dihydrochloride as a second-generation agent is defined by its chemically modified structure, a feature of its pharmacology. This structure specifically restricts its ability to penetrate the blood-brain barrier effectively, setting it apart from older, first-generation agents. This modification allows the medication to block peripheral H₁ receptors effectively while generally being categorized as non-sedating at therapeutic levels. This modern profile minimizes the chance of the user experiencing drowsiness compared to older allergy medicines. This characteristic makes Cetirizine the preferred agent for managing everyday symptoms, such as seasonal allergy symptoms, without disrupting routine activities.


Cent's Composition and Available Forms

Cent is formulated as a single-ingredient product designed for oral administration, ensuring a rapid and systemic effect throughout the body once absorbed. It is available in multiple pharmaceutical preparations, including solid forms such as the tablet and capsule, and liquid forms, specifically the oral solution and syrup. The availability of both solid and liquid dosage forms ensures the medication can be easily administered to a wide range of users, including adults and pediatric patients who may require the easier consumption offered by a liquid base. This variety allows for broad use across different age groups, a feature that supports patient compliance.


What is the General Purpose of Cent?

The general purpose of Cent is to help relieve the uncomfortable physical manifestations resulting from an allergic response through selective H₁ blockade. By precisely interrupting the action of the body's natural chemical mediator, histamine, the medication achieves its general goal of providing relief from the irritation, swelling, and excessive fluid production characteristic of chronic itch and widespread allergic responses. Its long-acting profile provides reliable symptom control for extended periods. This medicine reliably maintains relief from allergy symptoms over a full day.

Regulatory References

  1. Cetirizine: MedlinePlus Drug Information

What side effects are possible with Cent?

Possible side effects and safety information

The official safety profile for Cetirizine Dihydrochloride (Cent) is structured by government regulatory bodies, classifying reported adverse reactions based on their frequency and the physiological system affected.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on incidence rates documented in clinical trials and post-marketing surveillance. The most frequently observed reactions, classified as Common (affecting up to 1 in 10 people), include Somnolence (drowsiness), Headache, Fatigue, Dizziness, and Dry mouth.

Reactions listed as Uncommon (affecting up to 1 in 100 people) include Diarrhoea and Agitation. Rare (up to 1 in 1,000) reactions include Convulsions, Tachycardia (increased heart rate), and severe forms of Hypersensitivity.

System-Organ Classes and Serious Events

Adverse reactions primarily involve the Nervous System (e.g., somnolence, headache) and the Gastro-intestinal System (e.g., dry mouth, nausea).

Serious Adverse Reactions officially documented in regulatory sources, though rare, include life-threatening events such as Anaphylactic Shock and serious systemic effects like Convulsions.

Population-Specific Safety Considerations

Official safety statements note that dose adjustments are required for patients with moderate to severe Renal Impairment because the active substance is primarily eliminated through the kidneys. Caution is also advised when prescribing to older adults due to potentially reduced clearance. Furthermore, the official prescribing information advises caution for patients with predisposing factors for Urinary Retention, such as prostatic hyperplasia.

Exposure-Related Safety Notes

The regulatory data includes reports of new-onset severe Pruritus (itching) that may occur after stopping daily, long-term use of the medication.

Overdose and Emergency Response

Officially documented overdose presentations for Cetirizine Dihydrochloride typically follow ingestion exceeding five times the recommended daily dose. The clinical picture primarily involves Central Nervous System (CNS) effects, ranging from common signs like drowsiness (somnolence), sedation, dizziness, and headache to more pronounced states of restlessness or irritability. Overdose may also present with anticholinergic-like findings, specifically urinary retention, mydriasis (pupil dilation), and tachycardia (fast heart rate).

The regulatory profile documents that severe manifestations, including seizures, coma, and cardiorespiratory collapse, constitute life-threatening outcomes. For any suspected overdose, immediate medical attention must be sought. Urgent emergency help is required if the affected person has collapsed, experiences a seizure, shows trouble breathing, or can’t be awakened.

Management is defined as symptomatic and supportive treatment, as regulatory documents state that no known specific antidote exists for Cetirizine. Due to the clearance profile, the drug is not effectively removed by dialysis. Monitoring, including cardiac monitoring and ECG assessment, may be necessary for large ingestions. Furthermore, the risk and duration of toxicity are officially noted to be increased in the elderly and individuals with renal impairment due to reduced clearance.

Therapeutic Uses of Cent

What Cent Treats: Main Uses and Benefits

Cent is commonly used across conditions characterized by episodic or fluctuating symptom patterns, primarily targeting allergic rhinitis (hay fever) and its year-round form. It helps address groups of symptoms that may appear suddenly, such as persistent sneezing, profuse runny nose (rhinorrhea), and itchy eyes, and may assist in managing these noticeable manifestations.


Relief for Chronic Urticaria and Skin Itch

The medication is applicable in conditions marked by periods of increased physiological tension, notably for managing chronic idiopathic urticaria (hives). It is used when symptoms create noticeable interference with daily stability, and is used to help manage the intensity of pruritus (skin itchiness) and the presence of weals, thereby contributing to easing the overall symptom load.


Supportive Relief Across Symptom Domains

Cent provides support that helps ease the overall burden of symptoms in situations requiring temporary assistance in symptom stabilization, particularly for mild to moderate allergic responses. This supports symptom management and is often applied during phases where the patient experiences heightened discomfort, and supports patients during episodes of heightened discomfort.


Quick Fact: Relief for Itchy Skin and Hives

Cent is commonly used to help manage the symptoms of chronic urticaria, supporting patients during acute flares of pruritus and the associated appearance of weals (hives).

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Cent?

This section outlines the official eligibility rules for Cent (Cetirizine Dihydrochloride) as documented by governmental regulatory authorities. Eligibility is determined by age, pre-existing health conditions, and specific physiological states.


Absolute Non-Eligibility (Contraindications)

Cent is strictly contraindicated and must not be used by individuals who have a known hypersensitivity or allergic reaction to the active ingredient, any non-active components (excipients), or to Hydroxyzine (the drug from which Cetirizine is derived). Use is also prohibited for patients with severe renal impairment (kidney failure) due to the risk of the drug accumulating in the body.


Eligibility by Age and Condition

Population Group Regulatory Status and Limitation
Adults and Adolescents Approved for use from 12 years of age and older.
Children Approved minimum age varies by formulation, often 6 years and older for tablets, and as young as 6 months for specific liquid forms under prescription.
Renal Impairment Patients with mild or moderate kidney impairment require conditional use with a mandatory dose reduction.
Pregnancy/Lactation Avoided or Not Recommended. Use during pregnancy should be avoided unless the potential benefit outweighs the risk; use is not recommended while breastfeeding as the drug is excreted in human milk.

What should I know about interactions with other medicines?

Cent Interactions with Other Medicines and Products

It is crucial to inform your healthcare provider and pharmacist about all medicines you are currently taking, including prescription and non-prescription drugs, vitamins, and herbal or dietary supplements. This helps prevent potentially dangerous drug-drug interactions that can alter the effectiveness or increase the side effects of Cent or the other medications.

Significant Drug Interactions

Cent is primarily metabolized by certain liver enzymes, particularly the Cytochrome P450 (CYP) enzymes. Medications that inhibit these enzymes may increase the concentration of Cent in the blood, potentially leading to increased risk of side effects. Conversely, drugs that induce these enzymes can decrease Cent's effectiveness by lowering its blood concentration.

  • CYP Enzyme Inhibitors: Strong inhibitors of certain CYP enzymes, such as some antifungals (e.g., ketoconazole, fluconazole), HIV protease inhibitors, and certain macrolide antibiotics (e.g., clarithromycin), can significantly raise Cent levels. Your doctor may need to adjust your Cent dosage or monitor you closely if you take these together.
  • CYP Enzyme Inducers: Strong inducers, including certain antiseizure medications (e.g., phenytoin, carbamazepine) and the antibiotic rifampin, can reduce the efficacy of Cent.

Other Interactions

Cent should be used cautiously with other medications that share similar side effects, such as causing drowsiness or affecting cardiac rhythm, as this may lead to additive adverse effects. Alcohol consumption should also be limited or avoided, as it can heighten the central nervous system depressant effects or other side effects associated with Cent. Consult your doctor for personalized advice regarding Cent and any potential food or supplement interactions that may affect its absorption or metabolism.

Mechanism of Action

How Cent Works: Mechanism of Action

Cent is a modulator that works at the biological level to influence the electrical signaling of the nervous system.


Modulation of Peripheral Ion Channels

The primary mechanism of Cent is the non-competitive inhibition of specific voltage-gated sodium channels (Na v1.7 and Na v1.8) found on peripheral sensory neurons. It stabilizes these channels in their inactivated state, limiting the flow of positive sodium ions, which is critical for generating action potentials. This leads to an attenuation of electrical signal propagation at the peripheral source.


Influence on Nociceptive Signaling Cascades

This selective blockade initiates a cascade that modulates nociceptive signaling in the peripheral nervous system, particularly in hyperexcitable nerve fibers. The reduction in action potential firing along these sensory pathways means that the transmission of signals to the spinal cord and brain is modulated. This core mechanistic action influences the physiological effect of attenuated sensory signal transmission and reduced nerve excitability.

Dosage and Administration Information

Administration Guidelines for Cent (Cetirizine Dihydrochloride)

Cent is available in both oral (tablet, solution, syrup) and intravenous (IV) forms, with usage protocols defined by the route chosen. The standard daily administration schedule is once every 24 hours.

Administration Scope

Property Detail
Route of administration Primary route is Oral; the Intravenous route is used for specific acute conditions.
Standard Dosing The maximum recommended oral dose for adults and adolescents (12 years and older) is 10 mg once daily.
Timing in relation to meals Oral forms may be taken with or without food.
Preparation/Intake Liquid oral forms must be measured using the dosing device supplied with the product, not a kitchen spoon. Tablets are generally swallowed whole.
Missed-dose rule If a dose is forgotten, it should be taken when remembered, but a double dose must not be administered to compensate.

Population-Specific Use Rules

Dose adjustments are required for certain patient groups:

  • Renal Impairment: For adults with moderate-to-severe kidney function impairment, the dose must be reduced. For example, some regimens recommend 5 mg once every 2 days for severe impairment (estimated eGFR <30 mL/min).
  • Older Adults (≥65 years): A starting dose of 5 mg once daily is often suggested due to potential age-related decline in renal function.
  • Pediatric Dosing (2 to <6 years): The typical regimen starts at 2.5 mg once daily (liquid form), with an option to increase to 5 mg once daily or administer as 2.5 mg twice daily, depending on the specific product label.

Connection to Established Use Protocols

Established guidelines describe Cent as a once-daily oral medicine for most cases, with a requirement for dose adjustment in patients with reduced renal function to prevent excessive systemic levels. These protocols govern the procedural details of administration, including how liquid forms must be measured and the rule against double dosing.

Recent Clinical Evidence

Cent: Recent Clinical Evidence

Recent clinical research on Cent (cenobamate) has focused primarily on its use as an add-on therapy for adults with uncontrolled focal (partial-onset) seizures. These studies aim to describe the drug's safety profile and its observed effect on seizure frequency.

Primary Efficacy Findings

Multicenter, double-blind, randomized, placebo-controlled trials have been essential in evaluating Cent. The primary outcome measure in these studies was typically the percentage change in 28-day focal seizure frequency from baseline. Key findings reported across various doses (100 mg, 200 mg, and 400 mg) included a reduction in focal seizure frequency that was statistically greater than that observed in the placebo group. Responder rates (the percentage of participants who achieved a 50% reduction in seizure frequency) also showed a dose-related increase.

Secondary Endpoints and Study Populations

Secondary endpoints examined in these trials often included the rate of seizure freedom (no reported seizures during the maintenance phase) and evaluation of the drug's safety profile.

Study Endpoint Finding Reported in Trials
Seizure Freedom Rates were higher in the active treatment groups compared to placebo.
Specific Populations Research has specifically explored outcomes in patients with previous epilepsy-related surgery and those with refractory epilepsy, indicating its study in complex treatment-resistant cases.

Safety and Long-Term Data

Ongoing open-label extension studies provide long-term data regarding the duration of observed efficacy and the safety profile over extended periods. Observed adverse events were generally reported more frequently with higher doses, leading to a dose-dependent increase in treatment discontinuation rates. Continued data collection across diverse patient subgroups helps inform the overall understanding of Cent's clinical profile.

Frequently Asked Questions (FAQ)

Common questions about Cent (FAQ)


Safety and Use

Q: Is Cent okay to take long-term?

A: Official regulatory documents mention that after long-term, daily use of Cent, there have been reports of severe itching (pruritus) that may occur upon stopping the medication. This observation is part of the drug's documented safety profile. Concerns regarding the duration of treatment, particularly long-term use, are best reviewed with a healthcare provider.

Q: Can Cent be crushed or split if it's hard to swallow?

A: The official administration guidelines indicate that standard tablets are generally intended to be swallowed whole. Only specific oral forms of Cent, such as chewable or orally disintegrating tablets, are designed to be chewed or dissolved. Patients are encouraged to review the instructions for their specific product form, as altering the tablet in an unapproved way could potentially affect the medication’s intended action.

Q: What does 'contraindicated' mean for Cent?

A: The term contraindicated is used in official regulatory documents to identify a situation where the medication must not be used by an individual. This is due to a pre-existing medical factor or condition, such as severe kidney impairment, where using the drug poses a documented risk that outweighs any potential benefits.

Q: Do I need to take Cent at the same time every day for it to work best?

A: The practice of taking Cent at approximately the same time each day is described in regulatory information. This consistency is intended to help maintain a steady level of the drug in the bloodstream. Maintaining consistent drug levels supports the medication's effectiveness over the full 24-hour dosing period.

Q: Does Cent have a Black Box Warning?

A: The official prescribing information for Cent does not include a Black Box Warning. This is the most stringent type of safety warning the FDA can issue, and its absence means the drug's safety profile does not warrant this level of extreme caution.

Q: Is Cent addictive or habit-forming?

A: Cent is not classified as a controlled substance by regulatory bodies such as the FDA. Therefore, it is not generally considered to be addictive or habit-forming.

Q: Can Cent make my skin sensitive to the sun?

A: Official adverse event data indicates that photosensitivity reactions have been reported as an infrequent side effect of Cent. Photosensitivity is an increased sensitivity of the skin to exposure to sunlight.

Q: Do I need to have regular blood tests while on Cent?

A: Routine or mandatory laboratory monitoring, such as regular blood tests, is not typically required by the official prescribing information for Cent. The prescribing information details necessary precautions but does not include a requirement for general laboratory work.

Q: Can Cent affect fertility or conception?

A: Preclinical data from animal studies are required by regulatory agencies to evaluate potential effects on reproduction. These studies suggest potential effects on offspring development at doses significantly higher than the maximum human dose. Any concerns regarding the potential impact on fertility are best directed to a healthcare provider.


Drug Properties and Interactions

Q: How quickly does Cent start working?

A: Clinical pharmacology data suggests that the onset of action generally occurs within 30 minutes to one hour after oral administration.

Q: How long does Cent stay in your system?

A: The amount of time Cent remains in the body is quantified by its elimination half-life. Official clinical pharmacology data indicates the average elimination half-life is approximately 10 hours in adults.

Q: Does Cent cause weight gain?

A: Studies and official information indicate that increased weight has been reported as an infrequent adverse event during clinical trials. Adverse events are officially classified based on the rate at which they were observed in study populations.

Q: Does Cent interact with common pain relievers like ibuprofen?

A: Official regulatory sources, including those that detail drug-drug interactions, have indicated that no significant interactions have been found between Cent and common pain relievers such as ibuprofen. However, the prescribing information always advises informing a healthcare provider of all medicines being taken.

Q: Can Cent affect the results of lab tests?

A: The medication is not generally known to significantly interfere with the results of most routine laboratory tests. However, official safety data has occasionally noted temporary changes in liver enzyme levels.

Q: Is Cent gluten-free or lactose-free?

A: Official prescribing information (which lists inactive ingredients or excipients) indicates that some solid formulations of the drug contain lactose monohydrate. Information regarding whether the product is specifically gluten-free is not typically provided in the official prescribing documentation.


General Information

Q: Is Cent a new drug, or has it been around for a while?

A: Cent, which contains the active ingredient Cetirizine Dihydrochloride, is not a new drug. It first received regulatory approval in the early 1990s. It is classified as a second-generation antihistamine, distinguishing it from older compounds in its pharmacological class.

Q: Is Cent available over the counter?

A: Cent is categorized by regulatory agencies as an Over-the-Counter (OTC) drug in the United States and many other jurisdictions. This regulatory status means the medication can be purchased without a doctor's prescription.

Q: Is Cent the same drug as its generic version?

A: Cent is the brand name used for the active pharmaceutical ingredient Cetirizine Dihydrochloride. The generic version of the drug contains the exact same active ingredient and is considered therapeutically equivalent by regulatory agencies.

Q: Where can I find the official prescribing information for Cent?

A: Official prescribing information, safety data, and patient information leaflets can be found on government regulatory websites. These trusted resources include the FDA DailyMed database and the NIH MedlinePlus website.

How should Cent be stored and disposed of?

Official Storage and Disposal Requirements

The storage of Cent (Cetirizine Dihydrochloride) is governed by specific regulatory conditions to maintain stability, primarily focusing on temperature and environmental controls.

Storage Requirement Official Condition
Temperature Range Store at controlled room temperature, specifically 20^circC to 25^circC (68^circF to 77^circF).
Environmental Protection Keep the medication in a tightly closed container and away from excess heat and moisture (e.g., do not store in the bathroom).
Handling Restriction Protect liquid forms from freezing to prevent loss of stability.
Child Safety The product must be kept out of the sight and reach of children in a secure location.

When disposing of unused or expired Cent, do not discard it by pouring it into the toilet or down any drain. The official method is to utilize a local drug take-back program. If a take-back option is unavailable, the medication should be mixed with an undesirable substance, sealed in a plastic bag, and placed in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cent found in:

A-Z Index: